Publications by authors named "Sharik Hernandez-Rizo"

Despite abundant evidence correlating T cell CD38 expression and HIV infection pathogenesis, its role as a CD4T cell immunometabolic regulator remains unclear. We find that CD38's extracellular glycohydrolase activity restricts metabolic reprogramming after T cell receptor (TCR)-engaging stimulation in Jurkat T CD4 cells, together with functional responses, while reducing intracellular nicotinamide adenine dinucleotide and nicotinamide mononucleotide concentrations. Selective elimination of CD38's ectoenzyme function licenses them to decrease the oxygen consumption rate/extracellular acidification rate ratio upon TCR signaling and to increase cycling, proliferation, survival, and CD40L induction.

View Article and Find Full Text PDF

Caveolae-associated signaling toward mitochondria contributes to the cardioprotective mechanisms against ischemia-reperfusion (I/R) injury induced by ischemic postconditioning. In this work, we evaluated the role that the actin-cytoskeleton network exerts on caveolae-mitochondria communication during postconditioning. Isolated rat hearts subjected to I/R and to postconditioning were treated with latrunculin A, a cytoskeleton disruptor.

View Article and Find Full Text PDF

While combined antiretroviral therapy (cART) has had a great impact on the treatment of HIV-1 infection, the persistence of long-lived cells with an intact provirus precludes virus eradication and sterilizing cure. CRISPR/Cas9 genome editing has become an efficient tool to eradicate HIV-1 genome or prevent replication. Furthermore, regulation of Cas9 gene expression by HIV can induce mutations that could inactivate the proviral genome, making a gene therapy safe by preventing the induction of non-specific mutations, which could compromise the integrity of healthy cells.

View Article and Find Full Text PDF
Article Synopsis
  • GDF11 is identified as a crucial factor in regulating cell differentiation and has been poorly studied in cancer, especially in hepatocellular carcinoma (HCC), an aggressive liver cancer.
  • Treatment with GDF11 reduced the proliferation and colony forming ability of HCC cell lines, altering key cell cycle proteins and indicating compromised cell functionality.
  • Additionally, GDF11 treatment led to long-lasting effects on self-renewal capacity and significantly reduced cell migration and proliferation in vivo, suggesting its potential as a tumor suppressor in HCC.
View Article and Find Full Text PDF